Ledger.Open graph →
SEC Form D · filed October 25, 2018

Tivorsan Pharmaceuticals, Inc

Offering
$1.1M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Justin Fallon · Los Angeles, CADirectorCorey N. Fishman · Dublin, IrelandDirectorMichael Meyers · Los Angeles, CAExecJames Connolly · Los Angeles, CADirectorJohn Nicholson · Los Angeles, CADirectorPriscilla R. Sims-Brown · New York, NYDirectorGarland E. Faist · Chevy Chase, MDDirectorAlberto R. Gonzales · George Town, Grand Cayman, Cayman IslandsDirectorBenoit G. Sansoucy · Grand Cayman, Cayman IslandsDirectorLawrence Fuchs · New York, NYDirectorJudith M. Matthews · Dublin, IrelandDirectorScott R. Lennon · George Town, Grand Cayman, Cayman IslandsExecMichael M. Dunne · Dublin, IrelandExecDavid M. Kelly · Dublin, IrelandDirectorJay Venkatesan · Los Angeles, CADirectorRichard Gomel · New York, NYDirectorChandra L. Arandjelovic · New York, NYDirectorJoel Braunstein · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗